Effect of oral D-tagatose on liver volume and hepatic glycogen accumulation in healthy male volunteers

Regulatory Toxicology and Pharmacology

Volumn 33, Issue 2, 2001, Pages 257-267

  Boesch, Chris ^a   Ith, Michael ^a   Jung, Bruno ^a   Bruegger, Karin ^a   Erban, Sidona ^a   Diamantis, Ioannis ^a   Kreis, Roland ^a   Bär, Albert ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Bioresco AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; PLACEBO; SUCROSE; TAGATOSE;

ADULT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIETARY INTAKE; FOOD SAFETY; GLYCOGEN METABOLISM; HEPATOMEGALY; HUMAN; HUMAN EXPERIMENT; LIVER TOXICITY; LIVER WEIGHT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0034998602     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2001.1470     Document Type: Article

References (30)

1. Agius, L. (1994). Control of glucokinase translocation in rat hepatocytes by sorbitol and the cytosolic redox state. Biochem. J. 298(Pt. 1), 237-243.
2. Bär, A. (1999). Characteristics and significance of D-tagatose-induced liver enlargement in rats: An interpretative review. Regul. Toxicol. Pharmacol. 29, S83-S93.
3. Bär, A., Lina, B. A., de Groot, D. M., de Bie, B., and Appel, M. J. (1999). Effect of D-tagatose on liver weight and glycogen content of rats. Regul. Toxicol. Pharmacol. 29, S11-S28.
4. 13C MRS after oral and intravenous glucose administration. Magn. Reson. Med. 29, 583-590.
5. Bertelsen, H., Jensen, B. B., and Buemann, B. (1999). D-Tagatose - A novel low-calorie bulk sweetener with prebiotic properties. World Rev. Nutr. Diet 85, 98-109.
6. Boesch, C. (1999). Molecular aspects of magnetic resonance imaging and spectroscopy. Mol. Aspects Med. 20, 185-318.
7. Boesch, C., and Kreis, R. (2000). Imaging and spectroscopy of muscle. In Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy (Encyclopedia of Nuclear Magnetic Resonance) (I. R. Young, D. M. Grant, and R. K. Harris, Eds.), pp. 1307-1315. Wiley, Chichester, UK.
8. 31P-magnetic resonance spectroscopy. Metabolism 49, 1335-1339.
9. Donner, T. W., Wilber, J. F., and Ostrowski, D. (1999). D-Tagatose, a novel hexose: Acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes. Diabetes Obes. Metab. 1, 285-291.
10. Erard, M., Dick, R., and Zimmerli, B. (1986). Studie zum Lebensmittel-Pro-Kopf-Verzehr der Schweizer Bevölkerung. Mitt. Gebiete Lebensm. Hyg. 77, 88-130.
11. 13C NMR measurements of liver glycogen in vivo. Magn. Reson. Med. 31, 583-588.
12. 13C NMR spectroscopy of humans at 1.5 T. NMR Biomed. 2, 124-132.
13. 13C nuclear magnetic resonance spectroscopy study. J. Clin. Invest. 95, 783-787.
14. Jue, T., Rothman, D. L., Tavitian, B. A., and Shulman, R. G. (1989). Natural-abundance C-13 NMR study of glycogen repletion in human liver and muscle. Proc. Natl. Acad. Sci. USA 86, 1439-1442.
15. Kamber, M., Koster, M., Kreis, R., Walker, G., Boesch, C., and Hoppeler, H. (1999). Creatine supplementation - Part I: Performance, clinical chemistry, and muscle volume. Med. Sci. Sports Exerc. 31, 1763-1769.
16. Kruger, C. L., Whittaker, M. H., and Frankos, V. H. (1999a). Genotoxicity tests on D-tagatose. Regul. Toxicol. Pharmacol. 29, S36-S42.
17. Kruger, C. L., Whittaker, M. H., Frankos, V. H., and Schroeder, R. E. (1999b). Developmental toxicity study of D-tagatose in rats. Regul. Toxicol. Pharmacol. 29, S29-S35.
18. Kruger, C. L., Whittaker, M. H., Frankos, V. H., and Trimmer, G. W. (1999c). 90-Day oral toxicity study of D-tagatose in rats. Regul. Toxicol. Pharmacol. 29, S1-S10.
19. Laerke, H. N., and Jensen, B. B. (1999). D-Tagatose has low small intestinal digestibility but high large intestinal fermentability in pigs. J. Nutr. 129, 1002-1009.
20. Lee, A., and Storey, D. M. (1999). Comparative gastrointestinal tolerance of sucrose, lactitol, or D-tagatose in chocolate. Regul. Toxicol. Pharmacol. 29, S78-S82.
21. Raushel, F. M., and Cleland, W. W. (1977). Bovine liver fructokinase: Purification and kinetic properties. Biochemistry 16, 2169-2175.
22. Roberts, N., Cruz-Orive, L. M., Reid, N. M. K., Brodie, D. A., Bourne, M., and Edwards, R. H. T. (1993). Unbiased estimation of human body composition by the Cavalieri method using magnetic resonance imaging. J. Microsc. 171, 239-253.
23. Rognstad, R. (1975). Gluconeogenesis from D-tagatose by isolated rat and hamster liver cells. FEBS Lett. 52, 292-294.
24. Rognstad, R. (1982). Pathway of gluconeogenesis from tagatose in rat hepatocytes. Arch. Biochem. Biophys. 218, 488-491.
25. 14C]tagatose in the rat. Regul. Toxicol. Pharmacol. 29, S46-S56.
26. Seoane, J., Gomez-Foix, A. M., O'Doherty, R. M., Gomez-Ara, C., Newgard, C. B., and Guinovart, J. J. (1996). Glucose 6-phosphate produced by glucokinase, but not hexokinase I, promotes the activation of hepatic glycogen synthase. J. Biol. Chem. 271, 23756-23760.
27. Slotboom, J., Boesch, C., and Kreis, R. (1998a). Versatile frequency domain fitting using time domain models and prior knowledge. Magn. Reson. Med. 39, 899-911.
28. 13C NMR spectra of the liver. MAGMA 6(Suppl. 1), 209.
29. 13C magnetic resonance spectroscopy study. MAGMA 8(Suppl. 1), 225-226.
30. Vrana, A., and Fabry, P. (1976). Metabolic effects of high sucrose or fructose intake. World Rev. Nutr. Diet 42, 56-101.